These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 9721789)

  • 41. Pathogenesis of the syndrome of hemolysis, elevated liver enzymes, and low platelet count (HELLP): a review.
    Abildgaard U; Heimdal K
    Eur J Obstet Gynecol Reprod Biol; 2013 Feb; 166(2):117-23. PubMed ID: 23107053
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Coagulation and plasma fibronectin parameters in HELLP syndrome.
    Paternoster DM; Stella A; Simioni P; Mussap M; Plebani M
    Int J Gynaecol Obstet; 1995 Sep; 50(3):263-8. PubMed ID: 8543109
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Resistance to activated protein C and factor V Leiden.
    Perry DJ; Pasi KJ
    QJM; 1997 Jun; 90(6):379-85. PubMed ID: 9205675
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The factor V Leiden mutation increases the risk of venous thrombosis in patients with inflammatory bowel disease.
    Liebman HA; Kashani N; Sutherland D; McGehee W; Kam AL
    Gastroenterology; 1998 Oct; 115(4):830-4. PubMed ID: 9753484
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Is factor V Leiden a risk factor for fetal loss?
    Dulícek P; Chrobák L; Kalousek I; Pesavová L; Pecka M; Stránský P
    Acta Medica (Hradec Kralove); 1999; 42(3):93-6. PubMed ID: 10677895
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Resistance to activated protein C and the leiden mutation: high prevalence in patients with abruptio placentae.
    Wiener-Megnagi Z; Ben-Shlomo I; Goldberg Y; Shalev E
    Am J Obstet Gynecol; 1998 Dec; 179(6 Pt 1):1565-7. PubMed ID: 9855597
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Factor V Leiden mutation in relation to fecundity and miscarriage in women with venous thrombosis.
    van Dunné FM; Doggen CJ; Heemskerk M; Rosendaal FR; Helmerhorst FM
    Hum Reprod; 2005 Mar; 20(3):802-6. PubMed ID: 15618258
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The risk of recurrent deep venous thrombosis among heterozygous carriers of both factor V Leiden and the G20210A prothrombin mutation.
    De Stefano V; Martinelli I; Mannucci PM; Paciaroni K; Chiusolo P; Casorelli I; Rossi E; Leone G
    N Engl J Med; 1999 Sep; 341(11):801-6. PubMed ID: 10477778
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evaluation of smoking as a risk factor for activated protein C resistance during pregnancy.
    Kafkas S; Kalkan U; Bolaman Z; Sanci M; Yüksel H; Odabaşi AR
    Gynecol Obstet Invest; 2007; 64(2):89-94. PubMed ID: 17314487
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The factor V Leiden mutation and risk of renal vein thrombosis in patients with nephrotic syndrome.
    Irish AB
    Nephrol Dial Transplant; 1997 Aug; 12(8):1680-3. PubMed ID: 9269648
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Influence of factor VIII/von Willebrand complex on the activated protein C-resistance phenotype and on the risk for venous thromboembolism in heterozygous carriers of the factor V Leiden mutation.
    De Mitrio V; Marino R; Scaraggi FA; Di Bari L; Giannoccaro F; Petronelli M; Ranieri P; Tannoia N; Schiraldi O
    Blood Coagul Fibrinolysis; 1999 Oct; 10(7):409-16. PubMed ID: 10695766
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The factor V Leiden mutation may predispose women to severe preeclampsia.
    Dizon-Townson DS; Nelson LM; Easton K; Ward K
    Am J Obstet Gynecol; 1996 Oct; 175(4 Pt 1):902-5. PubMed ID: 8885745
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The role of natural anticoagulant deficiencies and factor V Leiden in the development of idiopathic portal vein thrombosis.
    Egesel T; Büyükasik Y; Dündar SV; Gürgey A; Kirazli S; Bayraktar Y
    J Clin Gastroenterol; 2000 Jan; 30(1):66-71. PubMed ID: 10636214
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Thrombosis in otherwise well children with the factor V Leiden mutation.
    Sifontes MT; Nuss R; Jacobson LJ; Griffin JH; Manco-Johnson MJ
    J Pediatr; 1996 Mar; 128(3):324-8. PubMed ID: 8774498
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of dabigatran on a prothrombinase-based assay for detecting activated protein C resistance: an ex vivo and in vitro study in normal subjects and factor V Leiden carriers.
    Gessoni G; Valverde S; Valle L; Caruso P; Gessoni F; Valle R
    Blood Transfus; 2017 Oct; 15(6):562-567. PubMed ID: 28287382
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Risk factors for clinical manifestations in carriers of Factor V Leiden and prothrombin gene mutations.
    DeSancho MT; Berlus N; Christos PJ; Rand J
    Blood Coagul Fibrinolysis; 2010 Jan; 21(1):11-5. PubMed ID: 19474699
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Age-specific incidence rates of venous thromboembolism among heterozygous carriers of factor V Leiden mutation.
    Ridker PM; Glynn RJ; Miletich JP; Goldhaber SZ; Stampfer MJ; Hennekens CH
    Ann Intern Med; 1997 Apr; 126(7):528-31. PubMed ID: 9092318
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Resistance to activated protein C--frequent etiologic factor for venous thrombosis.
    Simkova M; Simko F; Kovacs L
    Bratisl Lek Listy; 2001; 102(5):240-7. PubMed ID: 11725376
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Probability of recurrence of thrombosis in patients with and without factor V Leiden.
    Rintelen C; Pabinger I; Knöbl P; Lechner K; Mannhalter C
    Thromb Haemost; 1996 Feb; 75(2):229-32. PubMed ID: 8815565
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The relationship of the factor V Leiden mutation and pregnancy outcomes for mother and fetus.
    Dizon-Townson D; Miller C; Sibai B; Spong CY; Thom E; Wendel G; Wenstrom K; Samuels P; Cotroneo MA; Moawad A; Sorokin Y; Meis P; Miodovnik M; O'Sullivan MJ; Conway D; Wapner RJ; Gabbe SG;
    Obstet Gynecol; 2005 Sep; 106(3):517-24. PubMed ID: 16135581
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.